1. Home
  2. IMMP vs SGC Comparison

IMMP vs SGC Comparison

Compare IMMP & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • SGC
  • Stock Information
  • Founded
  • IMMP 1987
  • SGC 1920
  • Country
  • IMMP Australia
  • SGC United States
  • Employees
  • IMMP N/A
  • SGC N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • SGC Apparel
  • Sector
  • IMMP Health Care
  • SGC Consumer Discretionary
  • Exchange
  • IMMP Nasdaq
  • SGC Nasdaq
  • Market Cap
  • IMMP 251.8M
  • SGC 215.7M
  • IPO Year
  • IMMP N/A
  • SGC N/A
  • Fundamental
  • Price
  • IMMP $1.93
  • SGC $9.20
  • Analyst Decision
  • IMMP Buy
  • SGC Strong Buy
  • Analyst Count
  • IMMP 1
  • SGC 3
  • Target Price
  • IMMP $7.00
  • SGC $17.33
  • AVG Volume (30 Days)
  • IMMP 208.1K
  • SGC 30.8K
  • Earning Date
  • IMMP 10-10-2025
  • SGC 11-03-2025
  • Dividend Yield
  • IMMP N/A
  • SGC 5.79%
  • EPS Growth
  • IMMP N/A
  • SGC N/A
  • EPS
  • IMMP N/A
  • SGC 0.52
  • Revenue
  • IMMP $3,306,742.00
  • SGC $576,240,000.00
  • Revenue This Year
  • IMMP $16.82
  • SGC $1.63
  • Revenue Next Year
  • IMMP N/A
  • SGC $3.28
  • P/E Ratio
  • IMMP N/A
  • SGC $18.32
  • Revenue Growth
  • IMMP 31.28
  • SGC 4.03
  • 52 Week Low
  • IMMP $1.32
  • SGC $9.11
  • 52 Week High
  • IMMP $2.71
  • SGC $18.48
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 45.60
  • SGC 30.82
  • Support Level
  • IMMP $1.88
  • SGC $9.76
  • Resistance Level
  • IMMP $2.08
  • SGC $10.23
  • Average True Range (ATR)
  • IMMP 0.10
  • SGC 0.41
  • MACD
  • IMMP -0.03
  • SGC -0.01
  • Stochastic Oscillator
  • IMMP 4.97
  • SGC 10.37

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About SGC Superior Group of Companies Inc.

Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.

Share on Social Networks: